Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD476 for prevention of recurrent diverticulitis
2007-004896-20Phase 3Completed
- Sponsor
- Takeda
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Salcrozine in diverticulitis (4 arms), sponsored by Takeda. Primary endpoint: Proportion without recurrence of diverticulitis at Week 104. Started Feb 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
diverticulitis
Beyond the preview
Go deeper on 2007-004896-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004896-20.